Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster vires, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination

Journal of Infectious Diseases

Volumn 188, Issue 1, 2003, Pages 40-52

  Frey, Christian R ^a,b,d   Sharp, Margaret A ^a   Min, Andrew S ^a   Schmid, D Scott ^c   Loparev, Vladimir ^c   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD8 ANTIGEN; CHICKENPOX VACCINE; CYTOKINE; EPITOPE; PEPTIDE DERIVATIVE; PROTEIN; PROTEIN IE62; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ARTICLE; BLOOD; CHICKENPOX; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNITY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFECTION CONTROL; MEMORY CELL; MONONUCLEAR CELL; NORMAL HUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS DETECTION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CHICKENPOX; CHICKENPOX VACCINE; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 3, HUMAN; HLA-A2 ANTIGEN; HUMANS; IMMEDIATE-EARLY PROTEINS; MALE; MIDDLE AGED; TRANS-ACTIVATORS; VACCINATION; VIRAL ENVELOPE PROTEINS;

EID: 0038235688     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375828     Document Type: Article

References (37)

1. Arvin AM. Varicella-zoster virus. In: Knipe DM, Howleys P, eds. Fields virology. 4 ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins, 2001:2731-68.
2. Arvin A. Varicella-zoster virus: virologic and immunologic aspects of persistant infection. In: Ahmed R, Chen I, eds. Persistent Viral Infections: John Wiley & Sons, 1998:183-203.
3. Diaz PS, Smith S, Hunter E, Arvin AM. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Immunol 1989; 142:636-41.
4. Bowden RA, Levin MJ, Giller RH, Tubergen DG, Hayward AR. Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients. Clin Exp Immunol 1985; 60:387-95.
5. Hata A, Zerboni L, Sommer M, Kaspar AA, Clayberger C, Krensky AM, Arvin AM. Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. Viral Immunol 2001; 14:125-33.
6. Ihara T, Starr SE, Ito M, Douglas SD, Arbeter AM. Human polymor-phonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts. J Virol 1984; 51:110-6.
7. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12, and interferon-γ production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 1998; 178:940-8.
8. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994; 98:128-33.
9. Arvin AM, Kinney-Thomas E, Shriver K, et al. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol 1986; 137:1346-51.
10. + phenotype. J Immunol 1991; 146:257-64.
11. Giller RH, Winistorfer S, Grose C. Cellular and humoral immunity to varicella-zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis 1989; 160:919-28.
12. Hickling JK, Borysiewicz LK, Sissons JG. Varicella-zoster virus-specifc cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol 1987; 61:3463-9.
13. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67:1759-816.
14. Kinchington PR, Hougland JK, Arvin AM, Ruyechan WT, Hay J. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol 1992; 66:359-66.
15. Kinchington PR, Fite K, Turse SE. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J Virol 2000; 74:2265-77.
16. Sharp M, Terada K, Wilson A, et al. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J Infect Dis 1992; 165:852-8.
17. Arvin AM, Sharp M, Moir M, et al. Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frame 4, 10, 29, and 62 of varicella-zoster virus. Viral Immunol 2002; 15:1-10.
18. Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol 1997; 159:2802-6.
19. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicellazoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001; 75:4878-88.
20. + T cell responses to cytomegalovirus in normal donors. J Infect Dis 2002; 186:15-22.
21. Kern F, Surel IP, Brock C, et al. T-cell epitope mapping by flow cytometry. Nat Med 1998; 4:975-8.
22. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4:953-6.
23. Maecker HT, Dunn HS, Suni MA, et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 2001; 255:27-40.
24. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 1998; 34:207-15.
25. Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods 1998; 212:89-98.
26. Waldrop SL, Pitcher CJ, Peterson DM, Malno VC, Picker LJ. Determination of antigen-specific memory/effector CD4* T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. I Clin Invest 1997; 99:1739-50.
27. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 2000; 181:859-66.
28. Barany G, Merrifield RB. Solid-phase peptide synthesis. In: Gross E, Meienhoter J, eds. The peptides. VoI. 1. New York: Academic Press, 1980:1-284.
29. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50:213-9.
30. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 1994; 170:522-6.
31. + T cell responses by intracellular cytokine production. Immunol Lett 2001; 79:117-25.
32. Goulder PJ, Addo MM, Altfeld MA, et al. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays. J Virol 2001; 75:1339-47.
33. + T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999; 96:5692-7.
34. +-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol 1999; 73:8179-84.
35. + T cell cross-priming with exogenous antigens. J Immunol 2001; 166:7268-75.
36. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91:119-26.
37. Altfeld MA, Livingston B, Reshamwala N, et al. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J Virol 2001; 75:1301-11.